课题基金 / 基金详情

Promoting axon regneration and functional recovery after spinal cord injury

Promoting axon regneration and functional recovery after spinal cord injury
促进脊髓损伤后轴突再生和功能恢复
批准号:
7809817
负责人:
ZHIGANG HE
金额:
$44.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31

项目摘要

项目成果

ZHIGANG HE的其他基金

相似基金

相关文献

中文摘要
翻译
脊髓损伤破坏了大脑和脊髓之间的连接,通常 导致损伤部位以下的感觉和运动功能丧失。最 这种永久性功能缺陷的一个重要原因是受损的轴突不能 损伤后再生。原则上,功能恢复可以通过两种方法来实现 轴突再生的形式:受损轴突的再生, 它们最初的目标和形成新回路的备用轴突的发芽, 弥补失去的功能。我们最近的研究揭示了哺乳动物 靶向雷帕霉素(mTOR)途径,一个新的蛋白质合成的主要调节器, 成年视网膜神经节神经元轴突再生的关键决定因素。这一拟议 这项研究将集中在检查是否操纵mTOR活性的可能性, 能促进皮质脊髓下行轴突的再生和丢失的神经元的恢复。 脊髓损伤后的功能。我们希望这些实验将提供重要的 操纵mTOR通路促进轴突生长的治疗潜力 脊髓损伤后的再生和功能恢复。
英文摘要
Spinal cord injury disrupts the connections between the brain and spinal cord, often resulting in the loss of sensory and motor function below the lesion site. The most important reason for such permanent functional deficits is the failure of injured axons to regenerate after injury. In principle, the functional recovery could be achieved by two forms of axonal regrowth: the regeneration of lesioned axons which will reconnect with their original targets and the sprouting of spared axons that form new circuits and compensate for the lost function. Our recent studies reveal the activity of the mammalian target of rapamycin (mTOR) pathway, a major regulator of new protein synthesis, as a critical determinant of axon regrowth in the adult retinal ganglion neurons. This proposed study will focus on examining the possibility of whether manipulating the mTOR activity could promote the regrowth of descending corticospinal axons and restoration of lost functions after spinal cord injury. We expect that these experiments will provide important insights into the therapeutic potential of manipulating mTOR pathway in promoting axon regrowth and functional recovery after spinal cord injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism and Optimization of CBD-mediated analgesic effects
  • 批准号:
    10288673
  • 项目类别:
  • 资助金额:
    $13.22万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
KCC2 and spinal cord injury
  • 批准号:
    9884826
  • 项目类别:
  • 资助金额:
    $43.06万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
KCC2 and Spinal Cord Injury
  • 批准号:
    10599160
  • 项目类别:
  • 资助金额:
    $42.02万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
  • 批准号:
    10662464
  • 项目类别:
  • 资助金额:
    $67.09万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
海外基金